Schedule 13G ownership disclosure
Century Therapeutics, Inc.
Common Stock, $0.0001 par value per share · CUSIP: 15673T100
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Casdin Capital, LLC
Shares: 3,212,316.00 · Class: 3.7%
- Eli Casdin
Shares: 3,212,316.00 · Class: 3.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-003256
- Form type
- SCHEDULE 13G/A
- Filer
- Casdin Capital, LLC
- CIK
- CIK 1534261
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership